Isomorphic Labs Leads $5 B Series C Surge as UK AI Startups Secure Massive Funding for Drug Design, Chips and Defense
London’s Isomorphic Labs closed a $5 billion Series C round to expand its AI-powered drug discovery platform, while several other British AI firms attracted hundreds of millions for next‑gen chips and defense applications.